1.Clinical efficacy of various tumor markers in medical screening.
Ji Youn KIM ; Seong Chun SHIM ; Hyun Sik JEONG ; Seung Sei LEE
Korean Journal of Medicine 2001;60(2):148-155
BACKGROUND: Many tumor markers have been investigated for early diagnosis of the malignancy, yet they were turned out to be inappropriate for the purpose. This study was carried out to investigate the efficacy of tumor markers. METHODS: Employing radioimmunoassay, CEA, AFP, CA19-9, PSA, CA125 were done in 31,389 patients(20,878 males, 10,511 females) who visited our medical screening center from Jan. 1 1997 to Dec. 31 1997. RESULTS: Total mean value of CEA is 1.90+/-1.37 ng/mL(male: 2.17+/-1.37, female: 1.37+/-0.86). Male showed significantly higher level of CEA. Only 2 subjects had values over 25 ng/mL, and one was diagnosed to have stomach cancer but the other did not. Total mean value of AFP is 2.46+/-6.47 ng/mL (male: 2.32+/-3.55 ng/mL, female: 2.73+/-10.06 ng/mL). Female showed significantly higher level of measured AFP. One had AFP value over 400 ng/mL and was diagnosed of hepatoma. Total mean value of CA19-9 is 11.48+/-7.61 ng/mL,(male: 10.9+/-26.78 ng/mL, female: 12.61+/-8.97 ng/mL). Female showed significantly higher CA19-9. 65 subjects (male: 31, female: 34) showed measured CA19-9 level over 37 ng/mL. 5 subjects had values over 100 ng/mL and 1 subject was diagnosed of pancrease cancer. Total mean value of PSA is 0.79+/-1.88 ng/mL. 90 subjects showed measured PSA level over 4 ng/mL and mean value in this group was 10.92 ng/mL. 54 subjects were older than age 50. 4 out of 90 subjects were diagnosed of prostate cancer. Total mean value of CA125 is 13.08+/-10.93 ng/mL. 160 subjects showed measured CA125 level over 35 ng/mL. 19 subjects had value over 100 ng/mL and none of the malignancy was detected. CONCLUSION: Tumor markers are inappropriate measures for screening of malignancy.
alpha-Fetoproteins
;
Carcinoembryonic Antigen
;
Carcinoma, Hepatocellular
;
Early Diagnosis
;
Female
;
Humans
;
Male
;
Mass Screening*
;
Pancreas
;
Pancrelipase
;
Prostatic Neoplasms
;
Radioimmunoassay
;
Stomach Neoplasms
;
Biomarkers, Tumor*
2.Three Cases of Generalized Lichen Nitidus.
Sung Wook RO ; Joo Hyun SHIM ; Tae Jong CHUN ; Hyun Sang LIM ; Seong Jun SEO ; Meyung Nam KIM ; Chang Kwun HONG
Annals of Dermatology 1999;11(4):280-282
Lichen nitidus(LN) is an uncommon chronic inflammatory disease of shiny, flat-topped, flesh-colored uniform papules most commonly located on the penis, forearms and wrists, lower abdomen, and thighs. LN almost has localized distribution, but in rare cases, it may become generalized. In Korea, three cases of generalized LN were reported. We report here three cases of generalized lichen nitidus in 31-year-old man, 8-year-old boy, and 6-year-old girl who had generalized numerous pinhead-sized, erythematous to flesh-colored, shiny papules. Microscopically, they had typical appearance of LN.
Abdomen
;
Adult
;
Child
;
Female
;
Forearm
;
Humans
;
Korea
;
Lichen Nitidus*
;
Lichens*
;
Male
;
Penis
;
Thigh
;
Wrist
3.Relationship Between IgE-Mediated Basophil Histamine Releasability and Airway Hyperresponsiveness or Atopy Markers in Atopic Children.
Soo Jong HONG ; Jin Kyong CHUN ; Bong Seong KIM ; Jeong Yeon SHIM ; Sang Heon CHO ; Kyung Up MIN
Pediatric Allergy and Respiratory Disease 2000;10(4):299-307
BACKGROUND: Our previous data suggested that IgE-mediated histamine release from basophil was elevated in the atopic asthmatic children. Basophil may play an important role in the development of the IgE-dependent, late phase response in allergen induced airway disease. So the existence of enhanced basophil histamine release in asthma could promote airway reactivity and obstruction. PURPOSE: The purpose of this study is to determine the relationship between IgE-mediated basophil histamine releasability (BHR) and airway hyperresponsiveness or markers of atopy in atopic children. METHODS: Twelve atopic asthmatics and four healthy atopics who were sensitive to D.p and D.f were selected. Their median age was 11.2 years old, their mean serum IgE level was 897+/-276 IU/mL and mean total eosinophil count was 536+/-71/mm3. Total eosinophil counts, total IgE, D.p and D.f-specific IgE, pulmonary function test, and methacholine provocation test were performed. IgE-mediated basophil histamine release by D.f allergen and goat-antihuman IgE antibody were measured by automated fluorometric assay. The relationship between histamine release and airway hyperresponsiveness or atopic markers was investigated. RESULTS: PC20 inversely correlated with anti-IgE antibody-mediated BHR (r=-0.50, P<0.05). Serum total IgE concentration correlated with anti-IgE antibody-mediated BHR (r=0.54, P<0.05). Serum concentrations of specific IgE to D.p correlated with anti-IgE antibody-mediated BHR (r=0.66, P<0.05). PC20 correlated correlated with FEF25-75% (r=0.75, P<0.05) and inversely with the total eosinophil counts (r=-0.69, P< 0.01). CONCLUSION: IgE-mediated basophil histamine releasability is inversely correlated with airway hyperresponsiveness, and correlated with total or specific-IgE in atopic children. These findings suggest that basophil histamine releasability is easy and useful method of diagnosis and monitoring response to treatment in atopic disease.
Asthma
;
Basophils*
;
Child*
;
Diagnosis
;
Eosinophils
;
Histamine Release
;
Histamine*
;
Humans
;
Immunoglobulin E
;
Methacholine Chloride
;
Respiratory Function Tests
4.A Case of Aneurysmal Fibrous Histiocytoma.
Sung Nam CHANG ; Jeong Yun SHIM ; Seong Ho WEE ; Soo Il CHUN ; Wook Hwa PARK
Korean Journal of Dermatology 2000;38(9):1250-1252
Aneurysmal fibrous histiocytoma(AFH) is a histologic variant of dermatofibroma. The importance of the recognition of AFH as a variant of dermatofibroma lies in the differential diagnosis because the histologic appearance of AFH is very similar to dermatofibrosarcoma protuberans and other vascular malignancies, such as Kaposi's sarcoma and angiosarcoma. A 32-year-old man was seen for a nodular mass on the right popliteal fossa of 4 years' duration. The excisional biopsy specimen showed a relatively well circumscribed tumor mass in the dermis. In addition to compact storiform proliferation of spindle cells, there were multiple, irregular, blood-filled, aneurysmal tissue spaces that were devoid of lining of endothelial cells. Also, deposition of hemosiderin was prominent, particularly in the periphery of the aneurysmal spaces. Immunohistochemical stain for CD34 were negative to most tumor cells. After excisional therapy, there was no evidence of recurrence during the period of ten months' follow-up.
Adult
;
Aneurysm*
;
Biopsy
;
Dermatofibrosarcoma
;
Dermis
;
Diagnosis, Differential
;
Endothelial Cells
;
Follow-Up Studies
;
Hemangiosarcoma
;
Hemosiderin
;
Histiocytoma, Benign Fibrous*
;
Humans
;
Recurrence
;
Sarcoma, Kaposi
5.A Case of Rumination Syndrome with Simultaneous Repeatetive Contractions in Ambulatory 24 hour Antroduodenal Manometry.
Kwon Ho RYU ; Joon Seong LEE ; Hee Hyuk LIM ; Chang Bum YOO ; Jin Oh KIM ; Joo Young CHO ; Moon Sung LEE ; Chan Sup SHIM ; Boo Sung KIM
Korean Journal of Gastrointestinal Motility 2001;7(2):239-244
Rumination syndrome is defined as a regurgitation of recently ingested food into the mouth with subsequent remastication and reswallowing or spitting out, and absence of structural disease. This is infrequent in adults of normal mental capacity. The true prevalence of rumination syndrome is unknown because few people have medical attention and most of physicians do not recognize this syndrome as a disease. Upper gastrointestinal manometry has been reported to show a characteristic pattern that confirms the diagnosis, namely, the occurrence of synchronous pressure spikes termed "R waves" at all levels in the stomach and small intestine. We assessed a 49-year-old male patient who complained of frequent effortless regurgitation of food. Ambulatory short-segment antroduodenal manometry with pH-metry showed simultaneous repeatetive contractions in all segments associated with regurgitation.
Adult
;
Diagnosis
;
Humans
;
Intestine, Small
;
Male
;
Manometry*
;
Middle Aged
;
Mouth
;
Prevalence
;
Stomach
6.Endoscopic Findings of Newly Developed Gastrointestinal Lesions after Eradication for Helicobacter pylori.
Su Jin HONG ; Bong Min KO ; Jin Oh KIM ; Joo Young CHO ; Joon Seong LEE ; Moon Sung LEE ; Chan Sup SHIM
Korean Journal of Gastrointestinal Endoscopy 2002;24(1):6-10
BACKGROUND/AIMS: Eradication therapy for H. pylori infection is routinely used for treating patients with peptic ulcer disease. However, endoscopic findings after eradication therapy reveal some newly developed lesions. We have reviewed endoscopic findings to evaluate frequency and morphology of upper gastrointestinal lesions after eradication therapy for H. pylori. METHODS: We have studied 245 patients with peptic ulcer disease and H. pylori infection who had a successful eradication therapy. Endoscopic evaluation with rapid urease test, histology, and 13C-urea breath test was performed before eradication therapy and 6 weeks after. RESULTS: The incidence of newly developed lesions after eradication therapy was 14.3% at 6 weeks. The features of newly developed lesions after eradication therapy were as follows: 7 with reflux esophagitis (2.9%), 10 with acute gastritis (4.1%), 3 with duodenal ulcers (1.2%), 15 with erosive duodenitis (6.1%). These lesions were found during administration of H2 receptor blocker. No additional symptoms were found in these mucosal lesions. The development of these lesions was not related to duration of antibiotics. CONCLUSIONS: It is not rare to find some newly developed lesions after treatment of H. pylori infection. It is necessary to study pathogenesis of these lesions and have follow-up endoscopic examinations for a longer period of time.
Anti-Bacterial Agents
;
Breath Tests
;
Duodenal Ulcer
;
Duodenitis
;
Esophagitis, Peptic
;
Follow-Up Studies
;
Gastritis
;
Helicobacter pylori*
;
Helicobacter*
;
Humans
;
Incidence
;
Peptic Ulcer
;
Urease
7.Three cases of extensive liver metastasis in neuroendocrine tumors.
Eui Ju PARK ; Seong Ran JEON ; Dae Yong KIM ; Jae Young JANG ; Jung Hoon KIM ; So Young JIN ; Chan Sup SHIM
Korean Journal of Medicine 2009;76(Suppl 1):S15-S21
Malignant neuroendocrine tumors have the histological features of malignant tumors, and localized invasion and distant metastasis can occur. After clinical presentation, patients with neuroendocrine tumors usually show rapid deterioration. The first case involved a patient who underwent treatment for poorly differentiated adenocarcinoma of the lung. A percutaneous liver biopsy was performed to look for diffuse infiltration of the tumor in the liver. As a result, the patient was diagnosed with large-cell neuroendocrine carcinoma of the lung with diffuse liver metastasis. The other two patients presented with liver masses. Liver biopsies revealed metastatic neuroendocrine tumors of the liver. In patients presenting with diffuse hepatic infiltration of a tumor, a neuroendocrine tumor should be considered in the diagnosis, and immunohistochemical staining and further studies should be performed to locate the origin of the tumor. We report three cases of neuroendocrine tumors with diffuse liver metastasis.
Adenocarcinoma
;
Biopsy
;
Carcinoma, Neuroendocrine
;
Humans
;
Liver
;
Lung
;
Neoplasm Metastasis
;
Neuroendocrine Tumors
8.A Case of Pancreatic Duct-Portal Vein Fistulae in Pancreatic Cancer.
Hyun Jeong KIM ; Young Koog CHEON ; Jong Ho MOON ; Young Duck CHO ; June Seong LEE ; Moon Sung LEE ; Chan Sup SHIM
Korean Journal of Gastrointestinal Endoscopy 2005;31(2):130-133
Pancreatic fistulae follows pancreatic duct disruption and may develop as a complication of pancreatic disease or injury. The escaping fluid may be walled off by the surrounding viscera to form a pseudocyst or an abscess. Fistulae may drain spontaneously into adjacent hollow viscera or communicate with the body surface externally. Although internal pancreatic fistulas that communicate with adjacent internal organs are much less common, vascular communication with the pancreatic ductal system is especially unusual and generally represents a serious clinical situation. We experienced one case of pancreatic duct-portal vein fistula in a patient with pancreatic cancer. Endoscopic retrograde cholangiopancreatography revealed a large vascular structure representing the portal vein filled at the time of the contrast injection, indicating the presence of a pancreatic duct-portal vein fistulae.
Abscess
;
Cholangiopancreatography, Endoscopic Retrograde
;
Fistula*
;
Humans
;
Pancreatic Diseases
;
Pancreatic Ducts
;
Pancreatic Fistula
;
Pancreatic Neoplasms*
;
Portal Vein
;
United Nations
;
Veins*
;
Viscera
9.Effect of Double Bolus Urokinase on Thrombolysis in Acute Myocardial Infarction.
Seong Woon RHA ; Sang Won PARK ; Eun Mi LEE ; Kyo Seung WHANG ; Jung Chun AHN ; Woo Hyuk SONG ; Do Sun LIM ; Chang Gyu PARK ; Young Hoon KIM ; Hong Seog SEO ; Wan Joo SHIM ; Dong Joo OH ; Young Moo RO
Korean Circulation Journal 1997;27(11):1147-1159
BACKGROUND AND PURPOSE: Although thrombolytic strategies with streptokinase(STK) and tissue-type plasminogen activator(t-PA) in the treatment of acute myocardial infarction(AMI) have been studied in large-scale clinical trials in the western countries, such large-scale studies with urokinase(UK) are scanty. Even though UK is most commonly used thrombolytic agent for the treatment of AMI in Korea, there is no consensus on the dosage and the way of administration of UK in patients with AMI. Accordingly, a prospective clinical study was performed to evaluate the effects of thrombolytic strategies of intravenous double bolus method and standard double-infusion method with different dosage of UK in the treatment of AMI. SUBJECTS AND METHODS: Ninety there patients with AMI(male 75, female 18, age 57.5+/-10.8 years) were studied. The patients were divided into 3 groups according to dosage of UK and method of administration. Group I : 19 patients who received 1.5 million U of UK IV bolus, followed by 1.5 million U IV infusion for an hour(High Dose Group). Group II : 34 patients received 20,000U/kg body weight of UK IV bolus, followed by 20,000U/kg IV infusion for an hour(Double Dose Group). Group III : 40 patients received 1.5 million U of UK IV bolus and followed by 20,000U/kg IV bolus in 30 minutes with total dose of no more than 3 million U(Double Bolus Group). Coronary angiography(CAG) and left ventriculography(LVG) were performed 90 minutes after the administration of UK and post-AMI 7-10 days to investigate the patency of infarct-related artery(IRA) and LV function. Patency of IRA was graded according to the extent of flow of IRA. TIMI grade 0-1 was regarded as occluded, and grade 2-3 flow as patent. LV ejection fraction(EF) by echocardiography was measured on day 1, day 7-10 and 1 month after AMI. Indirect clinical parameters of thrombolysis were evaluated and were compared with CAG findings. RESULTS: 1) The 90 minutes IRA patency in Group III(Double bolus ; 79.0%) was higher than that in Group 1, but showed no statistically significant difference(High dose ; 61.5%, p=0.790). The 90 minutes IRA patency in Group III showed borderline significance with Group II(Double dose ; 57.1%, p=0.057). TIMI flow III in Group III(60.6%) was significantly higher than that in Group II(53.6%, p=0.0468) but showed no statistically significant difference with Group I(61.5%, p=0.158). 2) The EF by LVG were 49.1% in Group I, 41.7% in Group II and 49.2% in Group III. The difference in EF between Group I and Group III vs Group II was significant(p=0.008 in Group I, p=0.014 in Group III vs Group II). 3) Fatal bleeding complications(1 intracranial hemorrhage and 1 gastric ulcer bleeding) developed in Group II (Double dose). 4) Pain to door time, pain to needle time and door to needle time tended to be shorter in open(TIMI flow II-III) IRA group than in closed IRA group. 5) Initial EF were similar between open IRA group and closed IRA group(46.1% and 42.1% ; p=NS). The EF of open IRA group measured by LVG on initail coronary angiography(41.8% in closed IRA vs 48.0%, in open IRA, p=0.03) and by 2D-Echo on 7-10 day(41.7% in closed IRA vs 51.0% in open IRA, p=0.004) were better than those of closed IRA group. 6) Indirect clinical indices of reperfusion such as mean CPK peak, time to CPK peak significantly lower in open IRA group than in closed IRA group. 7) Fatal bleeding complications(1 intacranial hemorrhage and 1 gastric ulcer bleeding) developed in closed IRA group. CONCLUSION: The findings we observed in this trial showed that earlier initiation and more rapid infusion of UK were associated with more increased 90min patency of infarct-related artery and more improved LV function without any obviously increased bleeding complications or other serious life-threatening complications than conventional UK therapy. Specifically, double bolus IV injection of UK(1.5 million U bolus followed by 20,000 U/Kg bolus in 30min)was more effective method of thrombolysis than conventional method for achieving optimal reperfusion in AMI patients. Also, IRA patency at 90 minutes after the initiation of thrombolysis was important in preserving global LV function in early recovery phase of AMI. Further trials may be needed to determine more effective thrombolysis with UK in AMI.
Arteries
;
Body Weight
;
Consensus
;
Echocardiography
;
Female
;
Hemorrhage
;
Humans
;
Intracranial Hemorrhages
;
Korea
;
Myocardial Infarction*
;
Needles
;
Plasminogen
;
Prospective Studies
;
Reperfusion
;
Stomach Ulcer
;
Urokinase-Type Plasminogen Activator*
10.Efficacy of alcohol-free cetylpyridinium chloride on periodontal disease in beagle dogs via drinking water additive and oral gel.
Jae Kyong KIM ; Se Eun KIM ; Chun Sik BAE ; Kyung Mi SHIM ; Seok Hwa CHOI ; Soon Jeong JEONG ; Seong Soo KANG
Journal of Biomedical Research 2013;14(1):35-39
This study was conducted in order to examine the effects of alcohol-free cetylpyridinium chloride drinking water additive and oral gel on clinical parameters related to periodontal disease in beagle dogs. This study was conducted with healthy 15 beagle dogs. Following a professional teeth cleaning procedure, dogs were divided into three groups. Dogs in the control group received nothing, those in the drinking water additive (DWA) group received 800 ml water with 15 ml of alcohol-free cetylpyridinium chloride drinking water additive daily, and those in the Oral gel (OG) group were treated with oral gel containing alcohol-free cetylpyridinium chloride and 0.05% chlorhexidine gluconate daily. Clinical parameters, including plaque index (PI), calculus index (CI), and gingivitis index (GI) were evaluated at two and four weeks. Dogs in the DWA and OG groups had significantly less plaque than dogs in the control group at two and four weeks (P<0.01, P<0.05). And, at four weeks, CI was significantly lower in the OG group compared to the control group (P<0.05). On GI, similar scores were recorded for all groups during the experimental period. No significant difference was observed between the DWA group and the OG group. The effect of alcohol-free cetylpyridinium chloride drinking water additive was similar to the result for alcohol containing cetylpyridinium chloride mouthwash reported in a previous study. The effect in control of periodontal disease was better in the OG group because of additional chlorhexidine gluconate. However, use of drinking water additive will be more convenient for owners; thus, it will be more effective for achievement of long-term results.
Achievement
;
Animals
;
Calculi
;
Cetylpyridinium
;
Chlorhexidine
;
Dogs
;
Drinking
;
Drinking Water
;
Gingivitis
;
Periodontal Diseases
;
Tooth